Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
System L is a key sodium-independent transporter mediating cellular uptake/exchange of large neutral essential amino acids. Its major isoform LAT1 forms a heterodimer with CD98/4F2hc at cell membranes. Highly expressed at physiological barriers like blood-brain barrier—and upregulated in many cancers—it serves both vital nutritional roles and offers opportunities for targeted drug delivery or therapeutic intervention against malignancies.
Inhibition of amino acid transport, Facilitation of drug transport
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amino Acid Transporter System L (System L).